The Notch, PI3K/AKT, and Wnt/β-catenin pathways emerge as key players in this process, each contributing uniquely to glioma pathogenesis and offering potential targets for therapeutic intervention [12,34,39,61]. Here, AKT1 is linked to central nervous system cancer.